Articles On Creso Pharma (ASX:CPH)

–The below is a company sponsored announcement– Creso Pharma Limited ((CPH)), the ASX-listed, Swiss-based innovative medical cannabis product developer, has started 2020 strongly as it aims to brings the best of cannabis to better the liv...

ShareCafeCreso Pharma’s Technological Breakthrough Set To Expand Human Health Cannabis Product Line Creso Pharma Limited (ASX:CPH), the ASX-listed, Swiss-based innovative medical cannabis product developer, has started 2020 strongly as it a...

Special Report: Creso Pharma has unlocked a method to produce hemp oil-free plant based lozenges Creso Pharma (ASX:CPH) has successfully developed and tested its first hemp oil-free plant-based gum arabicum lozenges. The technological brea...

Hot on the heels of major developments in human and animal health, Creso Pharma (ASX:CPH) has achieved another key milestone: a technological breakthrough that will expand its cannaQIX® human health product line,

Creso Pharma has achieved a key technological milestone, developing its first water-soluble microgranulated hemp plant granules product as an expansion of its cannaQIX® human health product line. The news comes directly after the company an...

Creso Pharma (CPH) has secured up to an additional $17.4 million through a convertible securities agreement with L1 Capital Late last year, the company entered into agreements with professional and sophisticated investors to allow it to r...

Special Report: Cannabis products for pets is big business but just two ASX-listed companies are paying it much attention – and only one is making money in the sector. For some pet owners their beloved kitty or canine is their baby, and th...

–The below is a company sponsored announcement–  The global legal marijuana market size is expected to reach US$66.3 billion by the end of 2025. Growth will be fuelled by increasing legalisation and the growing adoption of cannabis as a p...

Creso Pharma (ASX:CPH, FRA:1X8) has announced its second major milestone for the year. Today is has informed the market that its flagship cannaQIX® line surpassed the milestone of 100,000 packs sold. The 100,000 pack milestone corresponds t...

Special Report: Creso Pharma has beaten a key sales milestone for its flagship hemp-derived supplement range. Creso Pharma (ASX:CPH) has beaten its 2.5m lozenge global sales milestone for the cannaQIX® line of hemp oil derived food suppleme...

Creso Pharma Limited (ASX:CPH, FRA:1X8) has informed the market that its flagship cannaQIX® line surpassed the milestone of 100,000 packs sold. The company has already delivered positive news flow throughout January resulting in its share p...

Cannabis stocks had a challenging year in 2019, but signs are emerging that a change of fortunes is in-store for the sector and a number of listed cannabis companies already look to be turning the corner. Over the longer term, there’s littl...

The survival of the southern Western Australia town of Collie is inextricably linked to the fortunes of the coal mines it was built on. But with the dire situation in coal escalating for the tiny town, cannabis could be its saving grace. Co...

–The below is a company sponsored announcement– Cannabis stocks had a challenging year in 2019, but signs are emerging that a change of fortunes is in store for the sector and a number of listed cannabis companies already look to be turni...

Creso Pharma (CPH) has now sold over 3 million doses of its anibidiol granule sachets since its launch in 2017 The granules are a form of complementary feed, designed to reduce stress and improve wellbeing in dogs. The hemp-derived range w...

Momentum has been building over the last couple of months as CresoPharma (ASX:CPH) outlined its strategy for generating substantial growth in 2020.

Cannabis and hemp supplier Creso Pharma (ASX: CPH) has updated the market with sales statistics showing that its anibidiol hemp oil products have benefited over 100,000 dogs with the rising “humanisation of pets” trend supporting demand for...

The THC Global Group Ltd (ASX: THC) share price has returned from its trading halt and rocketed higher. In morning trade the cannabis company’s shares are up 19% to 46 cents. Why is the THC Global share price rocketing higher? Investors ha...

Special Report: Creso Pharma has not only surged through critical milestones but also produced some strong quarterly revenue growth. An estimated 100,000 dogs have benefited from Creso Pharma‘s (ASX:CPH) anibidiol® hemp oil complementary fe...

Creso Pharma Limited (ASX:CPH, FRA:1X8) is pleased to announce that an estimated 100,000 dogs have benefited from the company’s anibidiol® hemp oil complementary feed range of products. This milestone corresponds to over 3 million sachets d...

Shares in Creso Pharma Limited (ASX:CPH, FRA:1X8) soared 20% on Friday after the company released its quarterly report for the three months to 31 December, 2019. Momentum has been building since early December as the company outlined its st...

Australian Ethical Investment (ASX:AEF) shareholders have seen spectacular growth this financial year, netting a return of over 200 per cent. The company’s funds under management (FUM) in the December quarter reached $3.87 billion. This is...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Roots Sustainable Agriculture Technology (ASX:ROO) has appointed Boaz Wachtel as CEO and Executive Chairman Former CEO and Chairman Sharon Devir will now assume the role of Executive Director and Business Development The changes are a pa...

Roots Sustainable (ASX:ROO) has nudged aside its CEO in favour of the founder, a man with marijuana experience, to take the company deeper into cannabis country. Sharon Devir, the CEO and chairman who listed the company in 2017, is being re...

The S&P/ASX 200 index was a strong performer in 2019, ending the year with a return of just over 20% excluding dividends. The benchmark index achieved this despite a number of wobbles along the way. Here are a few ASX lowlights for 201...

Marijuana is the hottest herb on the planet right now, but while investing in medical cannabis stocks could make you a fortune, it could also risk the house. After a flurry of activity on the ASX in 2017 as the sector kicked off following l...

Cann Global (ASX:CGB) has become the second small cap to enter the African cannabis market. It is a market that is estimated to reach $7.1 billion by 2023 although is only legal in three countries including South Africa, Zimbabwe and Lesoth...

Escrow Watch is Stockhead’s fortnightly recap of the small cap companies releasing shares that have been locked away in escrow. Escrow refers to shares that are held by early investors or directors restrained from selling for a year or two....

Africa is not usually front of mind when talking about the burgeoning cannabis market, but according to experts it offers a multi-billion-dollar opportunity for industry players. The UN estimates Africa sits only behind North America as a c...

–The below is a company sponsored announcement– Creso Pharma Limited ((CPH )) | (FRA:1X8) has begun launch preparations of the cannaQIX® range into Africa. Integrating into the African market is part of Creso’s drive to deliver its flagshi...

In a recent ASX update, Creso Pharma Limited (ASX: CPH, FRA: 1X8) notified that the launch preparations of its cannaQIX® product range in Africa are on track. The company intends to launch cannaQIX® range with the 11th largest pharmaceutica...

Creso Pharma (ASX:CPH | FRA:1X8) has announced that through Pharma Dynamics, Creso’s partner in the African region, initial orders worth approximately A$300,000 for the cannaQIX® product range have been made.

Creso Pharma Limited (ASX:CPH) has advised that the launch preparations of the cannaQIX® range with leading South African pharmaceutical company, Pharma Dynamics, a subsidiary of Lupin Limited (NSE:LUPIN) in the March quarter of 2020 is on...

Special Report: The medicinal cannabis company is on target to launch its cannaQIX® product range into South Africa in Q1 2020. Creso Pharma (ASX:CPH) has big plans for 2020, having laid the groundwork for a global distribution strategy acr...

It certainly has been a disappointing week for anyone that has invested in ASX cannabis shares. No less than four ASX cannabis shares sank to 52-week lows or worse on Thursday. Here’s why investors are dumping their shares: AusCann Group...

In 2018, a record number of companies publicly listed on exchanges with a combined capital accumulation of over US$18billion. Canada became the second and the largest country in the world to regulate cannabis for adult use. The US signed th...

Special Report: Creso Pharma’s first medical cannabis product has landed in Australia as the company sets itself up for 2020 as a truly global player in the industry. Creso Pharma’s (ASX:CPH) first shipment of its flagship medicinal cannabi...

Creso Pharma Limited (ASX:CPH | FRA:1X8) has commenced sales of its flagship medicinal cannabis product cannaQIX® 50 to Burleigh Heads Cannabis, one of Australia’s leading medicinal cannabis distribution companies. Burleigh Heads Cannabis h...

Legal weed could be a thing in New Zealand next year, but not before the populous decides whether it gets the go-ahead. Kiwis are set to participate in a 2020 cannabis referendum, and the government has just released a draft of what they’ll...

The Elixinol Global Ltd (ASX: EXL) share price has fallen 6.31% lower this morning after the Aussie cannabis group sold its Japanese operations yesterday.  What did Elixinol announce yesterday? In an after-market update, Elixinol confirmed...

Through partnerships with leading global companies, Creso Pharma (ASX:CPH) has been able to, and will continue to accelerate the development and distribution of its products worldwide.

The S&P/ASX 200 index has started the week in a positive fashion. In afternoon trade the benchmark index is up 0.6% to 6,888.4 points. Four shares that have failed to follow the market higher on Monday are listed below. Here’s why they...

Shares in ASX cannabis stock Creso Pharma Ltd (ASX: CPH) have plummeted 30% lower in early trade after emerging from a month-long trading halt. Why did Creso Pharma enter a trading halt? The ASX cannabis stock entered a trading halt on 1 N...

The last six months has been a rollercoaster ride for shareholders in Creso Pharma Limited (ASX:CPH) with the company’s shares receiving a significant boost in June following a proposed takeover valuing the cannabis products group at 63 cen...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Cannabis is a dynamic and rapidly growing sector with strong growth prospects. Countries like Canada, Germany, Norway, Thailand, Chile, Argentina, and Greece have legalised the use of medicinal cannabis, after recognizing its possible benef...

Creso Pharma Ltd (ASX: CPH) has today announced that its proposed acquisition by Canadian cannabis company PharmaCielo Ltd has been terminated by mutual agreement. The acquisition, which was to be implemented by scheme of arrangement, was...

A proposed acquisition of one of Australia's leading listed cannabis companies will not go ahead after its board heeded independent advice from BDO that the deal was "neither fair nor reasonable". Red flags were raised on Friday when Cres...

Each Monday, Stockhead recaps which stocks are most heavily in demand by investors — running hot. The analysis is based on the Relative Strength Index (RSI), a technical gauge which measures how trading momentum is affecting the price actio...